Arkolith/Insider Trading/INBP/Form 4/A

Kay E Gerald

Executive Chairman & President, Director, 10% OwnerINTEGRATED BIOPHARMA INC (INBP) · full profile →Form 4/A · filed May 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2022Option exercise(M)100K$0.23$23K5.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 6, 2022Option exercise(M)100K—$0150K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001053310-22-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML